These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Abscess formation in the pituitary fossa--report of a case and review of literatures (author's transl)]. Fukawa O; Mori T; Yoshimoto T; Sato S; Takaku A No Shinkei Geka; 1974 Sep; 2(9):637-41. PubMed ID: 4477643 [No Abstract] [Full Text] [Related]
44. [Hypophysectomy from the rhinologist's viewpoint]. Burian K HNO; 1969 Jul; 17(7):193-7. PubMed ID: 4931574 [No Abstract] [Full Text] [Related]
45. [ACTH--interpretation of test results]. Imura H; Matsukura S; Nakai Y Nihon Rinsho; 1973; 31():1584-90. PubMed ID: 4354896 [No Abstract] [Full Text] [Related]
46. Diagnosis and treatment of pituitary disease. Shimon I; Melmed S Psychother Psychosom; 1998; 67(3):119-24. PubMed ID: 9667058 [TBL] [Abstract][Full Text] [Related]
47. The society of Surgical Oncology Lucy Wortham James Research Award 1983. Radioimmunoassay in oncology. Yalow RS Cancer; 1984 Mar; 53(6):1426-31. PubMed ID: 6318963 [TBL] [Abstract][Full Text] [Related]
48. [Radio-immunologic determination of plasma ACTH]. Vague P; Oliver C Presse Med (1893); 1970 Apr; 78(18):848. PubMed ID: 4315077 [No Abstract] [Full Text] [Related]
49. [Study of hypophyseal somatotrophic function in physiology and patology]. Rüedi B; Felber JP; Aubert M; Magnenat P Rev Med Suisse Romande; 1969 Feb; 89(2):118-32. PubMed ID: 5770984 [No Abstract] [Full Text] [Related]
51. Interpreting prolactin levels: implications for the management of large pituitary lesions. Bevan JS Br J Neurosurg; 1991; 5(1):3-6. PubMed ID: 2021431 [No Abstract] [Full Text] [Related]
52. [The 10th Quality Control Survey for Radioisotope in vitro Tests in Japan, 1988. Subcommittee for Radioisotope in vitro Test, Medical and Pharmaceutical Committee, Japan Radioisotope Association]. Radioisotopes; 1989 Oct; 38(10):i-xxvii. PubMed ID: 2813858 [No Abstract] [Full Text] [Related]
53. The rational use of pituitary stimulation tests. Petersenn S; Quabbe HJ; Schöfl C; Stalla GK; von Werder K; Buchfelder M Dtsch Arztebl Int; 2010 Jun; 107(25):437-43. PubMed ID: 20644702 [TBL] [Abstract][Full Text] [Related]
54. ACTH immunoreactivities predominating in normal human plasma are not attributable to the human ACTH 1-39 molecule. Schöneshöfer M; Fenner A Biochem Biophys Res Commun; 1981 Sep; 102(1):476-83. PubMed ID: 6272797 [No Abstract] [Full Text] [Related]
56. [Efficient hypophyseal diagnosis through the combination of various function tests]. Böckel K; Wagner H; Grote G; Degenhardt G; Wenning N Verh Dtsch Ges Inn Med; 1974; 80():1318-23. PubMed ID: 4454410 [No Abstract] [Full Text] [Related]
59. [Experimental studies on ACTH determination with a new radioimmunoassay kit]. Ono T; Hattori S; Kawai K Horumon To Rinsho; 1977 May; 25(5):551-5. PubMed ID: 195757 [No Abstract] [Full Text] [Related]
60. Comments on the comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. Tordjman K; Jaffe A; Greenman Y; Stern N J Clin Endocrinol Metab; 1998 Dec; 83(12):4530; author reply 4532-3. PubMed ID: 9851806 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]